Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Duke University Names Dr. Megan Clowse to Lead Rheumatology Division

Linda Childers  |  Issue: February 2024  |  February 10, 2024

Dr. Clowse

In October 2023, Megan E.B. Clowse, MD, MPH, a renowned expert in the field of rheumatology and immunology, was named the new chief of the Division of Rheumatology and Immunology at Duke University School of Medicine, Durham, N.C. Dr. Clowse, who serves as an associate professor of medicine in Duke’s Division of Rheumatology and Immunology and the Department of Population Health Sciences, says the new appointment comes during a significant realignment within the health system.

“We’re working toward optimizing the Division of Rheumatology within this new framework,” she says. “In addition, we’re striving to build collaborations between our providers, advanced practice providers and researchers to expand the work we’re doing. We’re looking to build on the success of the Duke Lupus Clinic, where a team of doctors and researchers works closely to turn clinical experience and data into discovery. Many of our faculty want to build similar teams to breach the gap between clinic and research.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Clowse says the division is also looking at increasing its educational offerings. “We already have an established fellowship program for advanced practice providers in rheumatology, which is unique, and we’re looking at ways to expand those offerings,” she says.

One of the ways Duke is addressing the rheumatology workforce shortage is by connecting with medical students earlier. “We have a lot of great educators on our faculty, which is allowing us to partner with medical students and residents very early in their training. We also have third-year medical students who spend a good quantity of time conducting research with us,” Dr. Clowse says. “We’re very involved in internship and residency rotations and have found that by interacting with students earlier, we’re increasing the number of medical students and residents who are interested in pursuing a career in rheumatology.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Duke is also working to recruit more diverse rheumatology providers. In a program, funded in part by a Diversity, Equity and Inclusivity award from the Arthritis Foundation, Lisa Criscione-Schreiber, MD, MEd, professor of medicine and vice chair for education in the Department of Medicine at Duke University School of Medicine, is educating medical students and providers about inclusive practices in rheumatology, while also recruiting more students from under-represented groups in medicine.

Improving Pregnancy Outcomes

Over the past two decades, Dr. Clowse has established a reputation as an international expert in how rheumatic diseases affect pregnancy. She’s the founder and director of the Duke Autoimmunity in Pregnancy Clinic, and has created two websites, LupusPregnancy.org and ReproRheum.Duke.edu, to assist rheumatologists in providing care to pregnant women with rheumatic diseases.

Page: 1 2 3 | Single Page
Share: 

Filed under:CareerProfiles Tagged with:Dr. Megan ClowseMovers & Shakerspregnancy

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Rheumatology Medications with Limited Safety Data: How Do We Use Them in Pregnant Patients?

    December 6, 2022

    How does a rheumatologist treat a pregnant woman when many medications are not approved for pregnancy or safety data are limited?

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Rheumatic Disease & Reproductive Health

    November 21, 2023

    SAN DIEGO—In the Review Course at ACR Convergence 2023, Dr. Megan Clowse spoke on the subject of reproductive counseling for patients with rheumatic conditions, a topic that has been the focus of much of her research and scholarship.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences